Literature DB >> 28077840

Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases.

Xiaomei Luo1, Yongyi Zou1, Bo Tan1, Yue Zhang1, Jing Guo1, Lanlan Zeng1, Rui Zhang1, Hu Tan1, Xianda Wei1, Yiqiao Hu1, Yu Zheng1, Desheng Liang1,2, Lingqian Wu1,2.   

Abstract

GATA zinc finger domain-containing 2B (GATAD2B) is a subunit of the methyl-CpG-binding protein-1 complex (MECP1), which deacetylates methylated nucleosomes and regresses transcriptional activity. Recently, GATAD2B has been elucidated as a candidate gene in patients with intellectual disability (ID). In this study, we identified two novel heterozygous frameshift mutations of GATAD2B in two unrelated ID cases through next-generation sequencing (NGS). Both of the mutations c.80_81insGATGT and c.552_555delGAAA cause truncated proteins that might be detrimental to neurodevelopment. We performed western blotting and observed a reduction in the target protein compared with normal controls. This is the first report of GATAD2B in Chinese ID patients. Our findings will broaden the spectrum of GATAD2B mutations and facilitate genetic diagnosis and counseling.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28077840     DOI: 10.1038/jhg.2016.164

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  3 in total

1.  GATAD2B Gene Microdeletion Causing Intellectual Disability Autosomal Dominant Type 18: Case Report and Review of the Literature.

Authors:  Milana Trubnykova; Jeny Bazalar Montoya; Jorge La Serna-Infantes; Flor Vásquez Sotomayor; María Del Carmen Castro Mujica; Hugo Hernán Abarca Barriga
Journal:  Mol Syndromol       Date:  2019-04-16

2.  Chromatin remodelling complexes in cerebral cortex development and neurodevelopmental disorders.

Authors:  Leora D'Souza; Asha S Channakkar; Bhavana Muralidharan
Journal:  Neurochem Int       Date:  2021-05-06       Impact factor: 3.921

Review 3.  Chromatin Remodeling Complex NuRD in Neurodevelopment and Neurodevelopmental Disorders.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  Front Genet       Date:  2019-07-24       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.